Clark D Kensinger1,2, Irene D Feurer1,2,3, Heather W O'Dell2, David C LaNeve2, Lindsey Simmons2, C Wright Pinson1,2, Derek E Moore4,5. 1. Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA. 2. Vanderbilt Transplant Center, Nashville, TN, USA. 3. Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA. 4. Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA. derek.moore@vanderbilt.edu. 5. Vanderbilt Transplant Center, Nashville, TN, USA. derek.moore@vanderbilt.edu.
Abstract
BACKGROUND: The effect of awarding MELD exception points for hepatocellular carcinoma (HCC) on patient-reported outcomes (PROs) is unknown. We evaluated the physical and mental health-related quality of life (HRQOL) and symptoms of anxiety and depression in liver transplant recipients with HCC compared to patients without HCC. METHODS: The single-center sample measured PROs before and after transplant, which included 1521 multisurvey measurement points among 502 adults (67% male, 28% HCC, follow-up time: <1-131 months). Data were analyzed using multivariable mixed-effects models. RESULTS: Longitudinal PRO values did not differ between persons who received HCC exception points and those who did not have HCC. Patients with HCC who did not receive exception points had reduced physical HRQOL (P=.016), a late decline in mental HRQOL, and delayed reduction in anxiety (time-by-outcome interaction P<.050) compared to patients with HCC who received exception points. CONCLUSION: Transplant recipients who received HCC exception points had PROs that were comparable to those of patients without HCC, and reported better physical HRQOL and reduced symptoms of anxiety compared to patients with HCC who did not receive exception points. These analyses demonstrate the impact of HCC exception points on PROs, and may help inform policy regarding HCC exception point allocation.
BACKGROUND: The effect of awarding MELD exception points for hepatocellular carcinoma (HCC) on patient-reported outcomes (PROs) is unknown. We evaluated the physical and mental health-related quality of life (HRQOL) and symptoms of anxiety and depression in liver transplant recipients with HCC compared to patients without HCC. METHODS: The single-center sample measured PROs before and after transplant, which included 1521 multisurvey measurement points among 502 adults (67% male, 28% HCC, follow-up time: <1-131 months). Data were analyzed using multivariable mixed-effects models. RESULTS: Longitudinal PRO values did not differ between persons who received HCC exception points and those who did not have HCC. Patients with HCC who did not receive exception points had reduced physical HRQOL (P=.016), a late decline in mental HRQOL, and delayed reduction in anxiety (time-by-outcome interaction P<.050) compared to patients with HCC who received exception points. CONCLUSION: Transplant recipients who received HCC exception points had PROs that were comparable to those of patients without HCC, and reported better physical HRQOL and reduced symptoms of anxiety compared to patients with HCC who did not receive exception points. These analyses demonstrate the impact of HCC exception points on PROs, and may help inform policy regarding HCC exception point allocation.
Authors: Sammy Saab; Hillary Bownik; Noel Ayoub; Zobair Younossi; Francisco Durazo; Steven Han; Johnny C Hong; Douglas Farmer; Ronald W Busuttil Journal: Liver Transpl Date: 2011-05 Impact factor: 5.799
Authors: Adam Meier; Adam Yopp; Huram Mok; Pragathi Kandunoori; Jasmin Tiro; Amit G Singal Journal: Qual Life Res Date: 2014-12-13 Impact factor: 4.147
Authors: Robert T Russell; Irene D Feurer; Panarut Wisawatapnimit; Ronald M Salomon; C Wright Pinson Journal: J Gastrointest Surg Date: 2007-10-23 Impact factor: 3.452
Authors: Patrick Grant Northup; Nicolas Michael Intagliata; Neeral Lalit Shah; Shawn Joseph Pelletier; Carl Lansing Berg; Curtis Kent Argo Journal: Hepatology Date: 2014-10-29 Impact factor: 17.425
Authors: Franck Bonnetain; Xavier Paoletti; Sandra Collette; Michel Doffoel; Olivia Bouché; Jean Luc Raoul; Philippe Rougier; Fadil Masskouri; Jean Claude Barbare; Laurent Bedenne Journal: Qual Life Res Date: 2008-07-10 Impact factor: 4.147
Authors: Rachel C Forbes; Irene D Feurer; David LaNeve; Beatrice P Concepcion; Christianna Gamble; Scott A Rega; C Wright Pinson; David Shaffer Journal: Clin Transplant Date: 2018-03-30 Impact factor: 2.863
Authors: Kerstin Wohlleber; Patrick Heger; Pascal Probst; Christoph Engel; Markus K Diener; André L Mihaljevic Journal: Qual Life Res Date: 2021-07-20 Impact factor: 4.147